These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 36382475)

  • 61. Anti-Inflammatory Effects of Magnetically Targeted Mesenchymal Stem Cells on Laser-Induced Skin Injuries in Rats.
    Li X; Wei Z; Zhang W; Lv H; Li J; Wu L; Zhang H; Yang B; Zhu M; Jiang J
    Int J Nanomedicine; 2020; 15():5645-5659. PubMed ID: 32848391
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mesenchymal Stem Cell as a Potential Therapeutic for Inflammatory Bowel Disease- Myth or Reality?
    Adak S; Mukherjee S; Sen D
    Curr Stem Cell Res Ther; 2017; 12(8):644-657. PubMed ID: 28914206
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Biological Aspects and Clinical Applications of Mesenchymal Stem Cells: Key Features You Need to be Aware of.
    Saeedi M; Nezhad MS; Mehranfar F; Golpour M; Esakandari MA; Rashmeie Z; Ghorbani M; Nasimi F; Hoseinian SN
    Curr Pharm Biotechnol; 2021; 22(2):200-215. PubMed ID: 32895040
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bone marrow-derived clonal mesenchymal stem cells inhibit ovalbumin-induced atopic dermatitis.
    Na K; Yoo HS; Zhang YX; Choi MS; Lee K; Yi TG; Song SU; Jeon MS
    Cell Death Dis; 2014 Jul; 5(7):e1345. PubMed ID: 25032868
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Therapeutic Potential of Amniotic Fluid Derived Mesenchymal Stem Cells Based on their Differentiation Capacity and Immunomodulatory Properties.
    Harrell CR; Gazdic M; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
    Curr Stem Cell Res Ther; 2019; 14(4):327-336. PubMed ID: 30806325
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Regulation of pathophysiological and tissue regenerative functions of MSCs mediated via the WNT signaling pathway (Review).
    Zhang Q; Yu J; Chen Q; Yan H; Du H; Luo W
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278470
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical Potential and Current Progress of Dental Pulp Stem Cells for Various Systemic Diseases in Regenerative Medicine: A Concise Review.
    Yamada Y; Nakamura-Yamada S; Kusano K; Baba S
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845639
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Promising Tool in Retina Regeneration: Current Perspectives and Challenges When Using Mesenchymal Progenitor Stem Cells in Veterinary and Human Ophthalmological Applications.
    Cislo-Pakuluk A; Marycz K
    Stem Cell Rev Rep; 2017 Oct; 13(5):598-602. PubMed ID: 28643176
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The therapeutic potential of mesenchymal stem cells for cardiovascular diseases.
    Guo Y; Yu Y; Hu S; Chen Y; Shen Z
    Cell Death Dis; 2020 May; 11(5):349. PubMed ID: 32393744
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mesenchymal stem cells for inflammatory airway disorders: promises and challenges.
    Fan XL; Zhang Z; Ma CY; Fu QL
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30610158
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mesenchymal stem cells delivered in a microsphere-based engineered skin contribute to cutaneous wound healing and sweat gland repair.
    Huang S; Lu G; Wu Y; Jirigala E; Xu Y; Ma K; Fu X
    J Dermatol Sci; 2012 Apr; 66(1):29-36. PubMed ID: 22398148
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Directions for Enhancement of the Therapeutic Efficacy of Mesenchymal Stem Cells in Different Neurodegenerative and Cardiovascular Diseases: Current Status and Future Perspectives.
    Ahmed LA; Al-Massri KF
    Curr Stem Cell Res Ther; 2021; 16(7):858-876. PubMed ID: 33655876
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Diabetes Mellitus.
    Zhu L; Wang S; Qu J; Hui Z; Kan C; Hou N; Sun X
    Cell Reprogram; 2022 Dec; 24(6):329-342. PubMed ID: 35877064
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of mesenchymal stem cells in liver injury.
    Sun H; Shi C; Ye Z; Yao B; Li C; Wang X; Qian Q
    Cell Biol Int; 2022 Apr; 46(4):501-511. PubMed ID: 34882906
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Trends in using mesenchymal stromal/stem cells (MSCs) in treating corneal diseases.
    Venkatakrishnan J; Saeed Y; Kao WW
    Ocul Surf; 2022 Oct; 26():255-267. PubMed ID: 36240995
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mesenchymal stem cell therapy for immune-modulation: the donor, the recipient, and the drugs in-between.
    Nemeth K
    Exp Dermatol; 2014 Sep; 23(9):625-8. PubMed ID: 24863432
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The efficacy of different sources of mesenchymal stem cells for the treatment of knee osteoarthritis.
    Shariatzadeh M; Song J; Wilson SL
    Cell Tissue Res; 2019 Dec; 378(3):399-410. PubMed ID: 31309317
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immune modulation via adipose derived Mesenchymal Stem cells is driven by donor sex in vitro.
    Mckinnirey F; Herbert B; Vesey G; McCracken S
    Sci Rep; 2021 Jun; 11(1):12454. PubMed ID: 34127731
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Noval advance of histone modification in inflammatory skin diseases and related treatment methods.
    Zhang L; Chai R; Tai Z; Miao F; Shi X; Chen Z; Zhu Q
    Front Immunol; 2023; 14():1286776. PubMed ID: 38235133
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Epigenetic-modifying therapies: An emerging avenue for the treatment of inflammatory skin diseases.
    Yi JZ; McGee JS
    Exp Dermatol; 2021 Aug; 30(8):1167-1176. PubMed ID: 33752257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.